دورية أكاديمية

The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report.

التفاصيل البيبلوغرافية
العنوان: The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report.
المؤلفون: Neogi T; Boston University School of Medicine, Boston, Massachusetts, USA., Aletaha D, Silman AJ, Naden RL, Felson DT, Aggarwal R, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Khanna D, Kvien TK, Laing T, Liao K, Mease P, Ménard HA, Moreland LW, Nair R, Pincus T, Ringold S, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovský J, Wolfe F, Hawker G
مؤلفون مشاركون: American College of Rheumatology, European League Against Rheumatism
المصدر: Arthritis and rheumatism [Arthritis Rheum] 2010 Sep; Vol. 62 (9), pp. 2582-91.
نوع المنشور: Consensus Development Conference; Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 0370605 Publication Model: Print Cited Medium: Internet ISSN: 1529-0131 (Electronic) Linking ISSN: 00043591 NLM ISO Abbreviation: Arthritis Rheum Subsets: MEDLINE
أسماء مطبوعة: Publication: : Hoboken, N.J. : Wiley-Blackwell
Original Publication: Atlanta [etc.] Arthritis Foundation [etc.]
مواضيع طبية MeSH: Arthritis, Rheumatoid/*diagnosis , Rheumatology/*methods, Acute-Phase Reaction/complications ; Acute-Phase Reaction/pathology ; Arthritis, Rheumatoid/blood ; Arthritis, Rheumatoid/classification ; Arthritis, Rheumatoid/complications ; Clinical Chemistry Tests ; Consensus ; Decision Making, Computer-Assisted ; Decision Support Techniques ; Europe ; Evidence-Based Medicine ; Female ; Humans ; International Cooperation ; Male ; North America ; Societies, Medical ; Synovitis/complications ; Synovitis/pathology ; Terminology as Topic
مستخلص: Objective: The American College of Rheumatology and the European League Against Rheumatism have developed new classification criteria for rheumatoid arthritis (RA). The aim of Phase 2 of the development process was to achieve expert consensus on the clinical and laboratory variables that should contribute to the final criteria set.
Methods: Twenty-four expert RA clinicians (12 from Europe and 12 from North America) participated in Phase 2. A consensus-based decision analysis approach was used to identify factors (and their relative weights) that influence the probability of "developing RA," complemented by data from the Phase 1 study. Patient case scenarios were used to identify and reach consensus on factors important in determining the probability of RA development. Decision analytic software was used to derive the relative weights for each of the factors and their categories, using choice-based conjoint analysis.
Results: The expert panel agreed that the new classification criteria should be applied to individuals with undifferentiated inflammatory arthritis in whom at least 1 joint is deemed by an expert assessor to be swollen, indicating definite synovitis. In this clinical setting, they identified 4 additional criteria as being important: number of joints involved and site of involvement, serologic abnormality, acute-phase response, and duration of symptoms in the involved joints. These criteria were consistent with those identified in the Phase 1 data-driven approach.
Conclusion: The consensus-based, decision analysis approach used in Phase 2 complemented the Phase 1 efforts. The 4 criteria and their relative weights form the basis of the final criteria set.
References: Arthritis Rheum. 2009 Aug;60(8):2232-41. (PMID: 19644872)
Ann Rheum Dis. 2005 Oct;64(10):1510-2. (PMID: 15800005)
Arthritis Rheum. 2009 Nov 15;61(11):1472-83. (PMID: 19877103)
Ann Rheum Dis. 2010 Sep;69(9):1589-95. (PMID: 20699242)
Arthritis Rheum. 2010 Sep;62(9):2569-81. (PMID: 20872595)
معلومات مُعتمدة: 18475 United Kingdom ARC_ Arthritis Research UK; 18475 United Kingdom VAC_ Versus Arthritis; K23 AR055127 United States AR NIAMS NIH HHS; K23 AR055127-05 United States AR NIAMS NIH HHS
تواريخ الأحداث: Date Created: 20100928 Date Completed: 20101109 Latest Revision: 20220331
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC3077961
DOI: 10.1002/art.27580
PMID: 20872596
قاعدة البيانات: MEDLINE
الوصف
تدمد:1529-0131
DOI:10.1002/art.27580